EST Cathie Wood’s ARK Investment buys 370K shares of 10x Genomics (TXG) todayInvest with Confidence: Follow TipRanks' Top Wall Street ...

Cathie Wood's ARK ETFs have made their daily trades public for Wednesday, 29 January 2025, showcasing a series of strategic moves in the tech and biotech sectors. The most significant purchase was in ...

20:01 EST Cathie Wood’s ARK Investment buys 25K shares of 10x Genomics (TXG) today Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks ...

Cathie Wood's ARK ETFs have made their daily trades for Thursday, January 30th, 2025, with a notable pivot in their investment strategy. The funds executed a series of buys and sells across various ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Renowned investor Cathie Wood, CEO of Ark Invest believes President Donald Trump's second administration could breathe new ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Investing guru Cathie Wood remains an investor favorite ... investments in her “Big Ideas” monograph. Whether it is genomics, precision therapeutics, or artificial intelligence, her ETFs ...

"Our team delivered solid sequential revenue growth over last quarter," said Serge Saxonov, Co-founder and CEO of 10x Genomics. "We are confident the work we've done throughout 2024 sets us up ...

Across the recent three months, 6 analysts have shared their insights on 10x Genomics (NASDAQ:TXG), expressing a variety of opinions spanning from bullish to bearish. The table below summarizes ...

Cathie Wood's ARK Investment Management adds to its ... CEO Eric Lefkofsky highlights strong growth in genomics revenue, up 30%, and data and services revenue, which climbs 45%.